Patents by Inventor Catherine Van Wely

Catherine Van Wely has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VACCINE COMPRISING GP120 AND NEF AND/OR TAT FOR THE IMMUNIZATION AGAINST HIV
    Publication number: 20080102085
    Abstract: Use of a) an HIV Tat protein or polynucleotide; or b) an HIV Nef protein or polynucleotide; or c) an HIV Tat protein or polynucleotide linked to an HIV Nef protein or polynucleotide; and an HIV gp120 protein or polynucleotide in the manufacture of a vaccine suitable for a prime-boost delivery for the prophylactic or therapeutic immunisation of humans against HIV, wherein the protein or polynucleotide is delivered via a bombardment approach.
    Type: Application
    Filed: October 18, 2007
    Publication date: May 1, 2008
    Inventors: Peter Ertl, John Tite, Catherine Van Wely, Gerald Voss
  • Hiv-gag codon-optimised dna vaccines
    Publication number: 20070015721
    Abstract: The invention provides a nucleotide sequence that encodes an HIV-1 gag protein or fragment thereof containing a gag epitope and a second HIV antigen or a fragment encoding an epitope of said second HIV antigen, operably linked to a heterologous promoter. Preferred polynucleotide sequences further encodes nef or a fragment thereof and RT or a fragment thereof.
    Type: Application
    Filed: September 18, 2002
    Publication date: January 18, 2007
    Inventors: Andrew Beaton, Peter Ertl, Gerald Gough, Andrew Lear, John Tite, Catherine Van Wely
  • Adjuvant
    Publication number: 20050266024
    Abstract: The relates to certain adjuvant compositions, and to vaccine and/or nucleic acid immunization strategies employing such compositions. The invention in particular relates to DNA vaccines that are useful in the prophylaxis and treatment of HIV infections, more particularly when administered by particle mediated delivery.
    Type: Application
    Filed: March 19, 2003
    Publication date: December 1, 2005
    Inventors: Ralph Braun, Lindy Thomsen, Catherine Van-Wely, Peter Ertl
  • Adjuvant
    Publication number: 20050256070
    Abstract: The present invention relates to the fields of vaccines, vaccine adjuvants, molecular biology and immunology, and generally adjuvants and nucleic acid immunization techniques. More specifically, the invention relates to certain adjuvant compositions, and to vaccine and/or nucleic acid immunization strategies employing such compositions. The invention in particular relates to DNA vaccines that are useful in the prophylaxis and treatment of HIV infections, more particularly when administered by particle mediated delivery.
    Type: Application
    Filed: January 6, 2005
    Publication date: November 17, 2005
    Inventors: Ralph Braun, Lindy Thomsen, Catherine Van-Wely, Peter Ertl
  • Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv
    Publication number: 20050058657
    Abstract: Use of a) an HIV Tat protein or polynucleotide; or b) an HIV Nef protein or polynucleotide; or c) an HIV Tat protein or polynucleotide linked to an HIV Nef protein or polynucleotide: and an HIV gp 120 protein or polynucleotide in the manufacture of a vaccine suitable for a prime-boost delivery for the prophylactic or therapeutic immunisation of humans against HIV, wherein the protein or polynucleotide is delivered via a bombardment approach.
    Type: Application
    Filed: July 26, 2002
    Publication date: March 17, 2005
    Inventors: Peter Ertl, John Tite, Catherine Van Wely, Gerald Voss
  • Adjuvant
    Publication number: 20030190308
    Abstract: The present invention relates to the fields of vaccines, vaccine adjuvants, molecular biology and immunology, and generally adjuvants and nucleic acid immunization techniques. More specifically, the invention relates to certain adjuvant compositions, and to vaccine and/or nucleic acid immunization strategies employing such compositions. The invention in particular relates to DNA vaccines that are useful in the prophylaxis and treatment of HIV infections, more particularly when administered by particle mediated delivery.
    Type: Application
    Filed: March 19, 2002
    Publication date: October 9, 2003
    Inventors: Ralph P. Braun, Lindy Thomsen, Catherine Van-Wely, Peter Ertl